Texas Instruments Incorporated
—- Market cap
- —
- Debt
- +$14.05B
- Cash
- −$3.23B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: TXN stock price vs AVGO: inconclusive — current versus $264.89 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AVGO's multiple
Implied fair value · at TXN's multiple
Needs TXN P/E.
Close Dec 31, 2024
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
TEXAS INSTRUMENTS INCORPORATED · implied price per share
Bear
$20.64
Base
$24.46
Bull
$31.23
Broadcom Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe TXN can sustain its 23.2% ROIC and continue converting solid margins into steady growth, then holding or selectively accumulating makes sense because its quality metrics are strong even though the P/E-based valuation implies -3.9% downside.
TXN trades modestly above its P/E-implied value, with a current price of $275.74 versus an implied price of $264.89, implying -3.9% downside. The valuation case is mixed because TXN looks cheaper than AVGO on sales and EBITDA multiples, but not on earnings multiple where TXN is slightly richer.
Supporting Metrics